- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quantum BioPharma Ltd (QNTM)
Quantum BioPharma Ltd stock price live, this page displays NASDAQ QNTM stock exchange data. View the QNTM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Quantum BioPharma Ltd real time stock price chart below.
What Is the Quantum BioPharma Ltd Stock Price Today?
The Quantum BioPharma Ltd stock price today is 3.2000.
What Is the Stock Symbol for Quantum BioPharma Ltd?
The stock symbol for Quantum BioPharma Ltd is "QNTM."
What Stock Exchange Does Quantum BioPharma Ltd Trade On?
Quantum BioPharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Quantum BioPharma Ltd a Good Stock to Buy?
Determining whether Quantum BioPharma Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNTM quote. (ISIN: CA74764Y2050)
What Is the Quantum BioPharma Ltd Stock Price Today?
The Quantum BioPharma Ltd stock price today is 3.2000.
What Is the Stock Symbol for Quantum BioPharma Ltd?
The stock symbol for Quantum BioPharma Ltd is "QNTM."
What Stock Exchange Does Quantum BioPharma Ltd Trade On?
Quantum BioPharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Quantum BioPharma Ltd a Good Stock to Buy?
Determining whether Quantum BioPharma Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QNTM quote. (ISIN: CA74764Y2050)
Fair Value
An estimate of a Quantum BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2000
3.3899
52 wk Range
2.0700
21.0000
QNTM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Quantum BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.20003.3899
52 wk Range
2.070021.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QNTM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Quantum BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
12.5779
Upside
+293.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.5779
(+293.06% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.49 / --
Revenue / Forecast
-- / --
Compare QNTM to Peers and Sector
Metrics to compare | QNTM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQNTMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −21.2x | −0.4x | |
PEG Ratio | −0.02 | 0.01 | 0.00 | |
Price/Book | 3.3x | 5.5x | 2.6x | |
Price / LTM Sales | - | 0.0x | 3.0x | |
Upside (Analyst Target) | 293.3% | 331.1% | 55.1% | |
Fair Value Upside | Unlock | −21.5% | 8.2% | Unlock |
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company’s lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Quantum BioPharma (QNTM) Stock Price Today?
The Quantum BioPharma stock price today is 3.2000 USD.
What Stock Exchange Does Quantum BioPharma Trade On?
Quantum BioPharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Quantum BioPharma?
The stock symbol for Quantum BioPharma is "QNTM."
What Is the Quantum BioPharma (QNTM) Afterhours Price Today? (Afterhours variable test: 3.2700) Current Date: Sep 13, 2026
After hours price: 3.2700. After hours price change (units): 0.0700. Price change percentage: 2.1900%
What Is the Quantum BioPharma Market Cap?
As of today, Quantum BioPharma market cap is 25.8800M USD.
What Is Quantum BioPharma's Earnings Per Share (TTM)?
The Quantum BioPharma EPS (TTM) is -5.3537.
From a Technical Analysis Perspective, Is QNTM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Quantum BioPharma Stock Split?
Quantum BioPharma has split 2 times.
How Many Employees Does Quantum BioPharma Have?
Quantum BioPharma has 17 employees.
What is the current trading status of Quantum BioPharma (QNTM)?
As of Sep 13, 2026, Quantum BioPharma (QNTM) is trading at a price of 3.2000 USD, with a previous close of 3.2900 USD. The stock has fluctuated within a day range of 3.2000 USD to 3.3899 USD, while its 52-week range spans from 2.0700 USD to 21.0000 USD.
What Is Quantum BioPharma (QNTM) Price Target According to Analysts?
The average 12-month price target for Quantum BioPharma is 12.5779 USD, with a high estimate of 12.57785467 USD and a low estimate of 12.57785467 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +293.06% Upside potential.
What Is the QNTM Premarket Price?
QNTM's last pre-market stock price is 3.3000 USD. The pre-market share volume is 10,370.0000, and the stock has decreased by 0.0100, or 0.3000%.
What Is the QNTM After Hours Price?
QNTM's last after hours stock price is 3.2700 USD, the stock has decreased by 0.0700, or 2.1900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.